Skip to main content
Premium Trial:

Request an Annual Quote

Marina Ends Lease to Legacy R&D Facility for $1.2M in Stock


Marina Biotech said this week that it has terminated the lease to a Bothell, Wash., facility where the company conducted research and development related to its now-defunct intranasal drug operations.

Marina used the facility when it was Nastech Pharmaceutical, prior to its restructuring in 2008 as a pure-play RNAi and microRNA drug developer (GSN 5/08/2008). According to Marina President and CEO Michael French, the company hasn't occupied the building for three years.

According to a Marina filing with the US Securities and Exchange Commission, it signed an agreement with the building's owner to terminate the lease prior to its expiration date. In exchange, Marina will provide the landlord with 7.8 million shares of its common stock, which is currently trading around $0.15, a share for a total transaction value of about $1.2 million.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.